Psychiatric disorders in adults with cerebral palsy

McMorris, Carly A.; Lake, Johanna K.; Dobranowski, Kristin; McGarry, Caitlin; Lin, Elizabeth; Wilton, Derek H. C.; Lunsky, Yona; Balogh, Robert

doi:10.1016/j.ridd.2021.103859

Cited by 17 publications

(41 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Morbidity was measured using Resource Utilization Bands (RUBs), with higher levels representing the highest levels of expected resource use. 15 In addition, the prevalence of specific chronic conditions was calculated using validated disease algorithms for Ontarians with asthma, 16 diabetes, 17 hypertension, 18 chronic obstructive pulmonary disease (COPD), 19 dementia, 20 and epilepsy, 21 along with previously published algorithms for cerebral palsy 22 and mental health and/or addiction disorders developed in prior research with adults with IDD. 12…”

Section: Methodsmentioning

confidence: 99%

COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada

Lunsky

Durbin

Balogh

et al. 2022

Disability and Health Journal

Self Cite

View full text Add to dashboard Cite

Background Across and within countries there is a need to understand how the COVID-19 pandemic has impacted populations of individuals with intellectual and/or developmental disabilities (IDD). Objective Rates of COVID-19 positivity for adults with IDD, including Down syndrome, relative to adults without IDD in Ontario, Canada were compared. Health profiles and case-based rates of hospitalizations, intensive care unit admissions, and mortality within 30 days of testing positively were compared for those with IDD, including Down syndrome, versus those without IDD. Methods This retrospective cohort study linked health administrative databases using unique encoded identifiers to describe population-level COVID-19 positivity, related hospital use and mortality from January 15, 2020 to January 10, 2021. Incidence rate ratios (RR) and 95% confidence intervals were calculated. Results Relative to adults without IDD, COVID-19 positivity rates were 1.28 times higher for adults with IDD and 1.42 times higher for adults with Down syndrome. Compared to adults without IDD, adults with IDD were more than twice as likely to be hospitalized following COVID-19 (RR:2.21 (95%CI: 1.93,2.54)), and to die (RR:2.23 (95%CI: 1.86,2.67). These RRs were greater for adults under 65. For adults with Down syndrome, mortality rates were 6.59 (95%CI: 4.51,9.62) times higher than those without IDD. Discussion In Ontario, Canada, hospitalization and mortality rates associated with COVID-19 are higher for adults with IDD than other adults; These findings should inform vaccination strategies that often prioritize older adults in the general population resulting in people with IDD, who are often in younger age groups, being overlooked.

show abstract

Section: Methodsmentioning

confidence: 99%

COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada

Lunsky

Durbin

Balogh

et al. 2022

Disability and Health Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…Furthermore, in the adult CP population, studies showed a higher prevalence of all mental disorders ( 9 – 11 ); in particular, these patients have an increased risk for anxiety and depression ( 10 , 12 – 17 ).…”

Section: Introductionmentioning

confidence: 99%

“…For example, Van der Sloot ( 12 ) found an association of the level of motor impairment measured with the Gross Motor Function Classification System—Expanded & Revised (GMFCS-E&R) ( 18 ) but no difference based on sex. Other studies found that the occurrence of other impairments, such as epilepsy, gastrointestinal, or respiratory disorders, seemed to be unrelated ( 13 , 16 ) while the influence of a concurrent ID on mental health remained controversial ( 11 , 13 ). Whitney et al ( 17 , 19 ) found that several factors, as sleep disorders, pain and fatigue, were associated with different prevalence of mental health disorders.…”

Section: Introductionmentioning

confidence: 99%

Psychiatric symptoms in adult patients with cerebral palsy: A cohort study

Pizzighello

Uliana²,

Michielotto³

et al. 2022

Front. Neurol.

View full text Add to dashboard Cite

BackgroundPatients with cerebral palsy (CP) have an increased risk of developing mental health disorders.AimsThis paper is aimed to investigate the occurrence of psychiatric symptoms in adults with CP and to explore the relation between clinical and psychosocial variables.Methods and proceduresWe included 199 adults with a diagnosis of CP. The chi-square and the Mann-Whitney U tests were used to compare clinical and psychosocial variables, the level of perceived disability, and the type of observed parental style in patients with and without psychiatric symptoms. Logistic regression analysis was used to identify variables that could predict the occurrence of mental health disorders.Outcome and resultsAnxiety and psychosis were the most represented disorders. Age, living status, assumption of drugs, motor, manual, and global impairment were significantly different between patients with and without psychiatric symptoms. Similarly, a different parental style was observed between the two groups. Logistic regression indicated that living status, prescribed drugs, parental style, and the perceived disability in getting along with others predicted the occurrence of psychiatric symptoms.Conclusions and implicationsResults suggest that patients with and without psychiatric symptoms have different clinical and psychosocial characteristics. Some variables should be considered as potentially affecting the mental health of patients with CP.

show abstract

“…17 There may also be confounding symptoms and presentations when an individual may have multiple conditions, for example, the co‐occurrence of DS and ASD, 18 sensory impairments and psychiatric conditions, 19 schizophrenia and ID, 20 and CP and psychiatric disorder. 21 In addition, the presence of neuropsychiatric symptoms that can be categorized as behavioral and psychological symptoms of dementia (BPSD) and which may be already present independent of the pre‐existing condition, or exacerbated by it, can be a factor in confounding assessments. 22 Those adults with acquired brain injury (ABI) may have loss of vision or visual field cuts that impact performance on visual components of any assessment.…”

Section: Introductionmentioning

confidence: 99%

Examining older adults with neuroatypical conditions for MCI/dementia: Barriers and recommendations of the Neuroatypical Conditions Expert Consultative Panel

Janicki

Hendrix²,

McCallion

2022

Alz & Dem Diag Ass & Dis Mo

View full text Add to dashboard Cite

The Neuroatypical Conditions Expert Consultative Panel composed of numerous clinical and academic experts was convened to examine barriers to the examination of cognitive impairment in adults with a variety of neuroatypical conditions. Neuroatypical conditions affect normative intellectual development and function (such as intellectual disability and intellectual disability with conjoint psychiatric conditions), thought, moods, and cognition (such as severe mental illness), communication functions (such as the autism spectrum and hearing/vision impairments), and brain and motor function (such as cerebral palsy and acquired or traumatic brain injury). The panel concluded that current federal guidance for the assessment of cognitive impairment for mild cognitive impairment (MCI) or dementia does not sufficiently include information as to how to assess such adults. In addition, it concluded that adults with these conditions (1) challenge clinicians when attempting to discern current behavior and function from that which was pre‐existing; (2) often have inherent comprehension and oral communication difficulties, motor task performance impediments, and difficulty with visuals; and (3) pose difficulties when assessed with standardized dementia measures and can benefit from the use of specialized instruments. The panel recommended that federal guidance be broadened to include adaptations of assessment practices to accommodate neuroatypical conditions; that educational packs be developed for clinicians about such conditions and on detecting and diagnosing MCI or dementia; and that research be expanded to produce more evidence‐based information on both assessing adults with neuroatypical conditions for later‐life adult cognitive diseases/disorders and planning post‐diagnostic care.

show abstract

Psychiatric disorders in adults with cerebral palsy

Cited by 17 publications

References 37 publications

COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada

COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada

Psychiatric symptoms in adult patients with cerebral palsy: A cohort study

Examining older adults with neuroatypical conditions for MCI/dementia: Barriers and recommendations of the Neuroatypical Conditions Expert Consultative Panel

Contact Info

Product

Resources

About